Fullgreen Sustainable Biomedical Technology Introduces a More Stable and Easier-to-Implement Alternative: Cenanode™ INSIDE Technology

As exosome-related ingredients continue to attract attention in the skincare market, beauty brands are also facing more practical challenges: regulatory review, source verification, claim limitations, stability validation, batch consistency, and uncertainty in product launch timelines. At this exhibition, Fullgreen Sustainable Biomedical Technology introduces a new solution — Cenanode™ INSIDE, a Ceramide NP-based lipid nano-carrier technology designed to help brands create next-generation skincare products with stronger technological identity, formulation stability, and market differentiation.

In recent years, exosomes have become a highly discussed concept in beauty and skincare. However, for brands, using exosome-related ingredients is not simply a matter of adding a trending active. In Taiwan, the use of human cell-derived exosomes in cosmetics is subject to case-by-case review requirements, including documentation related to source, preparation, testing, safety, and stability. In addition, exosome or extracellular vesicle-related ingredients may face different regulatory considerations depending on their source, naming, and claims. For example, even non-animal sources such as plant- or microorganism-derived materials require careful claim management to avoid inconsistencies between product labeling and the actual ingredients used.

Beyond regulatory challenges, exosome-related materials may also involve stability and supply chain concerns. Storage conditions, freeze-thaw cycles, temperature fluctuations, and handling processes may affect particle size, concentration, active components, biological activity, and aggregation behavior. For brands, this means that developing exosome-inspired products may require more demanding cold-chain management, stability testing, quality control, and batch-to-batch verification.

Fullgreen Sustainable Biomedical Technology’s Cenanode™ INSIDE offers brand partners a clearer, more stable, and more commercially practical technology pathway. Built around Ceramide NP, Ceranode™ uses a skin-friendly lipid nano-carrier structure to incorporate various oil-soluble, botanical, soothing, repairing, and anti-aging active ingredients into nano-carriers. This helps improve the dispersion, compatibility, and storage stability of active ingredients within skincare formulations, while reducing the risk of phase separation, sedimentation, oxidation, and active degradation caused by processing conditions, temperature changes, or poor oil-water compatibility.

For brands, the greatest value of Cenanode™ is not merely replacing the market buzz around exosomes. It provides a more product-ready, scalable, and extendable technology platform. Depending on product positioning, Cenanode™ can be developed into different delivery concepts, including high-penetration delivery, long-release delivery, and zero-penetration surface protection. These can be applied across serums, lotions, repair creams, post-treatment skincare, sensitive-skin care, sunscreens, skin-enhancing skincare, men’s grooming, and day-to-night skincare systems.

Compared with exosome-related products that may be restricted by source, naming, claims, and stability requirements, Cenanode™ is better suited for brands seeking a verifiable, scalable, and expandable product story. It allows brands to build clear claims around ceramide lipid barrier support, stable active encapsulation, enhanced skin affinity, controlled release, and scenario-based skincare. Instead of simply following ingredient trends, brands can develop a true technology asset with stronger recognition and longer-term market value.

Fullgreen Sustainable Biomedical Technology states that the skincare market is shifting from “trending ingredient competition” toward “technology platform competition.” What brands need is not only the next popular active ingredient, but a solution that can reduce regulatory uncertainty, improve formulation stability, support efficacy storytelling, and quickly extend into multiple product lines. Cenanode™ INSIDE was developed precisely for this purpose.

Moving forward, Fullgreen Sustainable Biomedical Technology will continue to build on its Ceramide NP Cenanode™ platform to help brands develop more stable, more differentiated, and more consumer-relevant skincare products. With Cenanode™, brands no longer need to be limited by the regulatory and stability concerns often associated with exosome concepts. Instead, they can move forward with a more mature lipid nano-carrier technology to create the next generation of high-value skincare products.